Research Group for Pharmacogenomics

Group Director
Taisei MUSHIRODA
(Ph.D.)
Genetic variations in genes encoding proteins involved in drug metabolism, transport and response are of increasing importance for selecting particular drugs and an optimal dosages to provide the maximum effect and minimal adverse reactions for individual patients. The SNP-based approach makes us confident of achieving one of our goals, which is establishment of 'personalized medicine' that can provide the right drug at the appropriate dose for each individual patient. We also support SNP-based research using the center's technologies and knowledge in areas where SNP-based research for disease genes is not well developed. Our long-term goal is to establish an international SNP research network that will make the Center for Genomic Medicine a world leader in personalized medicine.
- Identification of gene(s) associated with drug responses
- Support for SNP-based research of overseas institutes using the center's technologies and knowledge
- Taisei MUSHIRODA
- Group Director